The Avandia debate.
Bloomgarden
Zachary T
ZT
Division of Endocrinology, Mount Sinai School of Medicine, New York, New York, USA.
D002317:Cardiovascular Agents / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000139:chemically induced*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
D002317:Cardiovascular Agents; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone